Chronic renal patients undergoing hemodialysis. Encounter for care involving renal dialysis
Conditions
Interventions
Intervention 1: Intervent Patients in the intervention group melatonin or 5-hydroxy trriptamin with a dose of 3 mg daily for I and received orally .Melatonin pill-shaped building was purchased from t
Sponsors
Oroumia University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patients should be at least two months before the start of the study are under dialysis Patients should not have smoking Principles of dialysis and dialysis person, long-term drug therapy during the study needs to be fixed.
Exclusion criteria
Exclusion criteria: The patient during the study to undergo the surgery pregnancy or breast-feeding during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum Glutathione. Timepoint: At the first of the study,30 and 60 days after start of melatonin. Method of measurement: eastbiopharm Lab kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Superoxiddismutase. Timepoint: At the first of study, 30 and 60 dayse after start of melatonin. Method of measurement: Nasdox Lab kit of navande salamat. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Rezai
Oroumia University of Medical Sciences
Outcome results
None listed